FDA Approves New Indications for ZOMACTON® (somatropin) as Ferring Plans Launch of Needle-Free Delivery System
ZOMACTON now approved for 5 pediatric and 1 adult indication Ferring will launch ZOMA-Jet® 10 Needle-Free Delivery System for…
-
-
Ferring’s heat-stable carbetocin could save thousands of women’s lives by preventing excessive bleeding after childbirth
New data show heat-stable carbetocin is as effective as oxytocin, the current standard of care, in preventing excessive bleeding…
-
NOCDURNA® (desmopressin acetate) Now Approved by U.S. FDA as First Sublingual Tablet to Treat Nocturia due to Nocturnal Polyuria
Clinical trials demonstrated an average reduction of nighttime voids of 52% in women and 43% in men relative to mean…
-
Ferring to Present Clinical Data on Efficacy and Safety of CLENPIQ TM (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep at Digestive Disease Week
Tuesday, June 5, 12:00-2:00 p.m., Dr. Lawrence Hookey to present “A Randomized, Assessor-Blinded, Multicenter Study Demonstrates the Efficacy and Safety…
-
Ferring signs global agreement to commercialise novel gene therapy for bladder cancer patients
rAd-IFN/Syn3, a novel gene therapy, is in Phase 3 development to treat high-grade non-muscle invasive bladder cancer patients, who…
-
Ferring acquires innovative biotechnology company and microbiome pioneer Rebiotix Inc.
• Rebiotix’s RBX2660 is a non-antibiotic treatment in Phase 3 development for the prevention of recurrent Clostridium difficile infection (CDI)…
-
Ferring’s CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Now Available
First and only FDA-Approved, Ready-to-Drink Low-Volume Bowel Prep Parsippany, NJ – February 12, 2018 – Ferring Pharmaceuticals Inc. announced today…
-
Ferring’s ZOMACTON® (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults
Ferring Expands U.S. Endocrinology Portfolio PARSIPPANY, N.J., January 31, 2018 – Ferring Pharmaceuticals Inc. today announced that the U.S. Food…
-
FDA APPROVES FERRING’S CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) ORAL SOLUTION FOR COLONOSCOPY PREP
New Ready-to-Drink Low-Volume Colonoscopy Prep in a Premixed Liquid Solution Parsippany, NJ – November 29, 2017 – The U.S. Food…
-
FERRING PHARMACEUTICALS PRESENTS NEW DATA COMPARING MENOPUR® (menotropins for injection) TO rFSH IN HIGH RESPONDER PATIENTS
PARSIPPANY, NJ (October 30, 2017) – Today Ferring Pharmaceuticals announced results from MEGASET HR, a 620 patient, prospective study comparing…